Skip to main content
SpringerLink
Log in

Diagnosis and Treatment of Premenstrual Syndrome

Differentiating Premenstrual Syndrome PMS from Premenstrual Dysphoric Disorder PMDD and Premenstrual Exacerbation Disorder PMED

  • Reference work entry
  • First Online:
Handbook of Gynecology

Abstract

Premenstrual disorders are characterized by the cyclical recurrence of mood changes and physical symptoms beginning in the luteal phase of the menstrual cycle and improving following menstruation. Diagnostic and management principles for PMS were established by the American College of Obstetrics and Gynecologists (ACOG), while the more severe Premenstrual Dysphoric Disorder has diagnostic criteria found in the Diagnostic and Statistical Methods of Mental Disorders, Fifth Edition (DSM-V). Establishing a diagnosis of PMS/PMDD requires the daily recording of symptoms for at least two menstrual cycles. A key aspect of diagnosis includes ruling out mood disorders and other medical conditions. Information surrounding pathophysiology is continually evolving, with current research focused on abnormalities in ovarian sex steroid metabolites that act as neuromodulators. A trial of conservative management is appropriate in some scenarios, but first-line pharmacologic therapy including combined oral contraceptives and selective serotonin reuptake inhibitors, is highly effective.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 999.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin: No 15; premenstrual syndrome. Obstet Gynecol. 2000;95(4):1–9.

    Google Scholar 

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.

    Book  Google Scholar 

  • Craner JR, Sigmon ST, McGillicuddy ML. Does a disconnect occur between research and practice for premenstrual dysphoric disorder (PMDD) diagnostic procedures? Women Health. 2014;54(3):232–44.

    Article  PubMed  Google Scholar 

  • de Wit AE, de Vries YA, de Boer MK, et al. Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials. Am J Obstet Gynecol. 2021;225(6):624–33.

    Article  PubMed  Google Scholar 

  • Eisenlohr-Moul T, Divine M, Schmalenberger K, et al. Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder. BMC Psychiatry. 2022;22(1):199.

    Article  PubMed  PubMed Central  Google Scholar 

  • Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health. 2006;9(1):41–9.

    Article  CAS  PubMed  Google Scholar 

  • Frank RT. The hormonal causes of premenstrual tension. Arch Neurol Psychiatr. 1931;26:1053–7.

    Article  Google Scholar 

  • Gastaldon C, Solmi M, Correll CU, Barbui C, Schoretsanitis G. Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies. Br J Psychiatry. 2022;221:1–12.

    Article  Google Scholar 

  • Gehlert S, Song IH, Chang CH, Hartlage SA. The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women. Psychol Med. 2009;39(1):129–36.

    Article  CAS  PubMed  Google Scholar 

  • Greene R, Dalton K. The premenstrual syndrome. Br Med J. 1953;1:1007–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology. 2003;28(Suppl 3):55–99.

    Article  CAS  PubMed  Google Scholar 

  • Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder-clinical procedures and research perspectives. Gynecol Endocrinol. 2004;19(6):320–34.

    Article  CAS  PubMed  Google Scholar 

  • Halbreich U, O’Brien PM, Eriksson E, Backstrom T, Yonkers KA, Freeman EW. Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder? CNS Drugs. 2006;20:523–47.

    Article  CAS  PubMed  Google Scholar 

  • Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020;12:100213.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hunter MS, Ussher JM, Browne SJ, Cariss M, Jelley R, Katz M. A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder. J Psychosom Obstet Gynaecol. 2002;23:193–9.

    Article  CAS  PubMed  Google Scholar 

  • Lustyk MK, Gerrish WG, Shaver S, Keys SI. Cognitive behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Women’s Ment Health. 2009;12:85–96.

    Article  Google Scholar 

  • Marjoribanks J, Brown J, O’Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013;6:CD001396.

    Google Scholar 

  • Prior JC, Vigna Y, Sciarretta D, Alojado N, Schulzer M. Conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-month trial. Fertil Steril. 1987;47:402–8.

    Article  CAS  PubMed  Google Scholar 

  • Rapkin AJ, Lewis EI. Treatment of premenstrual dysphoric disorder. Womens Health (Lond). 2013;9(6):537–56

    Google Scholar 

  • Sayegh R, Schiff I, Wurtman J, Spirers P, McDermott J, Wurtman R. The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol. 1995;86(4 pt 1):520–682.

    Article  CAS  PubMed  Google Scholar 

  • Schmidt PJ, Martinez PE, Nieman LK, et al. Premenstrual dysphoric disorder symptoms following ovarian suppression: triggered by change in ovarian steroid levels but not continuous stable levels. Am J Psychiatry. 2017;174(10):980–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Steinberg EM, Cardoso GM, Martinez PE, et al. Rapid response to fluoxetine in women with premenstrual dysphoric disorder. Depress Anxiety. 2012;29:531–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Steiner M, Li T. Luteal phase and symptom-onset dosing of SSRIs/SNRIs in the treatment of premenstrual dysphoria: clinical evidence and rationale. CNS Drugs. 2013;27:583–9.

    Article  PubMed  Google Scholar 

  • Taylor JW. Plasma progesterone, oestradiol 17 beta and premenstrual symptoms. Acta Psychiatr Scand. 1979;60:76.

    Article  CAS  PubMed  Google Scholar 

  • Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome; effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol. 1998;179:444–52.

    Article  CAS  PubMed  Google Scholar 

  • Vishnupriya R, Rajarajeswaram P. Effects of aerobic exercise at different intensities in premenstrual syndrome. J Obstet Gynaecol India. 2011;61:675–82.

    Article  CAS  PubMed  Google Scholar 

  • Wyatt KM, Dimmock PW, Frischer M, et al. The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta analysis. BJOG. 2004;111:585–93.

    Article  CAS  PubMed  Google Scholar 

  • Yonkers KA, Kornstein SG, Gueorguieva R, et al. Symptom-onset dosing of sertraline for the treatment of premenstrual dysphoric disorder: a randomized clinical trial. JAMA Psychiatry. 2015;72:1037–44.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA

    Zachary Anderson

Authors
  1. Zachary Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

    Donna Shoupe

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Anderson, Z. (2023). Diagnosis and Treatment of Premenstrual Syndrome. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-031-14881-1_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-14881-1_33

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-14880-4

  • Online ISBN: 978-3-031-14881-1

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation